Pharmafile Logo

OTC Awards

Hidden Heroes – Account Manager’s half-marathon for Alzheimer’s Society

As a business, we place tremendous value in community and giving back. That's why we're so proud to share the charitable achievements of our team.

Mednet

- PMLiVE

Janssen signs $2.5bn deal with Nanobiotix for late-stage radiotherapy enhancer

The agreement marks a significant boost to the Johnson & Johnson unit’s oncology pipeline

- PMLiVE

GSK’s Jemperli made available to endometrial cancer patients via UK’s early access scheme

Approximately 10,000 new cases of endometrial cancer are reported each year in the UK

- PMLiVE

Almirall’s Ilumetri shown to improve well-being of patients with plaque psoriasis

Almost 77% of psoriasis patients report that the condition negatively affects their well-being

- PMLiVE

Novavax’s COVID-19 vaccine granted full marketing authorisation in EU

The EC’s decision was supported by positive results from a phase 3 trial evaluating Nuvaxovid

- PMLiVE

Communiqué 2023: a celebration of excellence in healthcare communications

This year’s Awards, held at the London Grosvenor House Hotel, included 31 categories

Biogen Idec building

Biogen/Eisai’s Alzheimer’s disease drug granted full FDA approval

Leqembi was granted accelerated approval earlier this year for patients with early Alzheimer's disease

- PMLiVE

LifeArc launches rare disease programme with £100m investment

An initial £40m will go towards the creation of up to five rare disease research centres

Omnichannel

Going beyond the buzzword: omnichannel and healthcare marketing

The concept of omnichannel often gets confused with multichannel, with many pharma companies believing they are operating omnichannel when in fact it is a multichannel approach. In our latest blog,...

IGNIFI

How to Increase Engagement During Virtual Events

Tip #4 - How do you plan the agenda for your virtual event? We suggest to invite participant input to build and personalize the engagement. Check out our full top...

Impetus Digital

- PMLiVE

Takeda and F-star announce immunotherapy partnership worth over $1bn

Both companies will research and develop antibodies for new immuno-oncology targets

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links